Results 131 to 140 of about 1,119 (155)

Role of HDAC3 in the epithelial-mesenchymal transition of retinal pigment epithelium cells: Implications for proliferative vitreoretinopathy. [PDF]

Heliyon
Zou W, Huang C, Chen Y, Tang J, Li Q, Fang Q, Ma Y, Wu W, Feng S.   +8 more
europepmc   +1 more source

Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors. [PDF]

ACS Pharmacol Transl Sci
Schäker-Hübner L, Hansen FK.
europepmc   +1 more source

Histone Deacetylase Inhibition Enhances AQP3 Levels in Human Corneal Epithelial Cells and Corneal Wound Healing in Normoglycemic and Diabetic Male Mice. [PDF]

Cells
Melnyk S, Lu X, Ronderos V, Choudhary V, Johnson MH, Watsky MA, Bollag WB.   +6 more
europepmc   +1 more source

The role of HDAC3 in inflammation: mechanisms and therapeutic implications. [PDF]

Front Immunol
Watson N, Kuppuswamy S, Ledford WL, Sukumari-Ramesh S.   +3 more
europepmc   +1 more source

Correction to: Expanded CAG/CTG repeats resist gene silencing mediated by targeted epigenome editing. [PDF]

Hum Mol Genet
europepmc   +1 more source

Macrophagic HDAC3 inhibition ameliorates Dextran Sulfate Sodium induced inflammatory bowel disease through GBP5-NLRP3 pathway. [PDF]

Int J Med Sci
Che N, Zhang Y, Zhang S, Kong X, Zhang Y, Wang S, Yuan Z, Liao Y.   +7 more
europepmc   +1 more source

A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity. [PDF]

Nat Neurosci
Clayton BLL, Kristell JD, Allan KC, Cohn EF, Karl M, Jerome AD, Garrison E, Maeno-Hikichi Y, Sturno AM, Kerr A, Shick HE, Sepeda JA, Freundt EC, Sas AR, Segal BM, Miller RH, Tesar PJ.   +16 more
europepmc   +1 more source

CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemia. [PDF]

Nat Commun
Liu T, Wang T, Qi L, Liu Y, Shan M, Wang F, Fang Y, Liu S, Wen L, Chen S, Wu D, Xu Y.   +11 more
europepmc   +1 more source

Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis. [PDF]

Kidney Int
Wang Y, Jiao B, Hu Z, Wang Y.
europepmc   +1 more source

Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma. [PDF]

Transl Oncol
Havas AP, Tula-Sanchez AA, Steenhoek HM, Bhakta A, Wingfield T, Huntley MJ, Nofal AS, Ahmed T, Jaime-Frias R, Smith CL.   +9 more
europepmc   +1 more source